Meeting
2014 ASCO Annual Meeting
Bladder cancer risk: Use of PLCO and NLST to identify a suitable screening cohort.
Authors
Laura-Maria Krabbe
University Hospital of Muenster, Muenster, Germany
Laura-Maria Krabbe , Robert Scott Svatek , Shahrokh F. Shariat , Edward M. Messing , Yair Lotan
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Genitourinary (Nonprostate) Cancer
Track
Genitourinary Cancer
Sub Track
Bladder Cancer
Citation
J Clin Oncol 32:5s, 2014 (suppl; abstr 4546)
DOI
10.1200/jco.2014.32.15_suppl.4546
Abstract #
4546
Poster Bd #
114
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Quality Care Symposium
Improving tobacco treatment assistance and equity among patients with or without a UCD primary care provider at UCD Comprehensive Cancer Center, 2017-2021.
First Author: Nan Wang
Poster
2023 ASCO Genitourinary Cancers Symposium
Impact of race and payer status on the choice of urinary diversion among patients with localized bladder carcinoma undergoing cystectomy.
First Author: Abhishek Tripathi
Poster
2020 ASCO Quality Care Symposium
Closing the gap in health care disparities by improving the rate of lung cancer screening in an intercity hospital.
First Author: Anika Bhargava
Poster
2014 ASCO Annual Meeting
Previous cancer of spouse as a predictor for mortality after personal diagnosis of cancer.
First Author: Tamar Peretz